Vascular risk factors and Alzheimer's disease;Facteurs de risque vasculaire et maladie d'Alzheimer

Revue de Medecine Interne

Volumn 24, Issue SUPPL. 3, 2003, Pages

  Voisin, T ^a   Lugardon, S ^b   Balardy, L ^a   Vellas, B ^a  

^a Serv Univ Psychiat l'Enfant l'A   (France)

^b INSERM   (France)

Author keywords

Alzheimer's disease; Diabetes; High blood pressure; Hypercholesterolemia; Vascular risk factors

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BALANCE DISORDER; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE COURSE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; VASCULAR DISEASE;

EID: 0141997143     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)80685-9     Document Type: Article

References (11)

1. Munoz DG, Feldman H. Causes of Alzheimer's disease. CMAJ 2000;162:65-72.
2. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5.
3. Kivipelto M, Helkala EL, Laakso M, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissien A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-51.
4. Breteler MMB. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol of Aging 2000;21:153-160.
5. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteles MM, et al. Diabetes mellitus and the risk of dementia in a elderly population. The Rotterdam Study. Neurology 1999;53:1907-09.
6. Kalmijn S, Launer LJ, Ott A, Witterman JC, Hofman A, Bretelesn MM, et al. Dietary fat intake and the risk of dementia in a population-based study: the Rotterdam Study. Ann Neurol 1997;42:776-82.
7. Messier C, Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 1996;75:1-11.
8. Sparks DL, Scheff SW, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995;131:162-9.
9. Jellinger KA. Alzheimer disease and cerbrovascular pathology: an date. J Neural Transm 2002;109:813-6.
10. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol of Aging 2000;21:321-30.
11. Forette F, Seux ML, Staetten JA, Thigs L, Bukenhager WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.